Abstract
Although the reported number of infection related hospital days in peritoneal dialysis patients has decreased over the last decade, infection, in particular, peritonitis, remains the predominant issue in morbidity in peritoneal dialysis patients. Hospitalizations due to infectious complications in this population of end stage renal disease patients continue to exceed that due to cardiovascular related complications. Attempts to reduce infectious complications remain one of the primary focuses of any home dialysis program. Approach to infection is multi-faceted and includes ongoing education of staff and patient, preventive measures from time of peritoneal catheter placement to early measures at times of risk, and finally, tailored and effective treatment of peritonitis to avoid relapse and recurrence. The goal is maintaining the viability of the peritoneal membrane as a dialyzer and to avoid loss of the catheter with transfer of the patient to hemodialysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Collins AJ, et al. United States renal data system public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011). 2015;5(1):2–7. United States Renal Data System. 2015 USRDS annual data report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2015.
Miller TE, Findon G. Touch contamination of connection devices in peritoneal dialysis – a quantitative microbiologic analysis. Perit Dial Int. 1997;17(6):560–7.
Yap DY, et al. Risk factors and outcome of contamination in patients on peritoneal dialysis – a single-center experience of 15 years. Perit Dial Int. 2012;32(6):612–6.
Yip T, et al. Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int. 2007;27(5):560–4.
Bernardini J, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol. 2005;16(2):539–45.
Fried L, Bernardini J, Piraino B. Iatrogenic peritonitis: the need for prophylaxis. Perit Dial Int. 2000;20(3):343–5.
Strippoli GF, et al. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol. 2004;15(10):2735–46.
Li PK, et al. Ispd peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36:481–508.
Gadallah MF, et al. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kidney Dis. 2000;36(5):1014–9.
Kumar V. Predictors of peritonitis, hospital days and technique survival for periotneal dialysis patients in a managed care setting. Perit Dial Int. 2014;34(2):171–8.
Nessim SJ, et al. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol. 2009;4(7):1195–200.
Cnossen TT, et al. Comparison of outcomes on continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis: results from a USA database. Perit Dial Int. 2011;31(6):679–84.
Ruger W, et al. Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis. Perit Dial Int. 2011;31(1):39–47.
Chow KM, et al. Influence of peritoneal dialysis training nurses’ experience on peritonitis rates. Clin J Am Soc Nephrol. 2007;2(4):647–52.
Figueiredo AE, et al. Impact of patient training patterns on peritonitis rates in a large national cohort study. Nephrol Dial Transplant. 2015;30(1):137–42.
Bernardini J, et al. Peritoneal dialysis patient training, 2006. Perit Dial Int. 2006;26(6):625–32.
Lee SM, et al. Comparison of exit site infection and peritonitis incidences between povidone-iodine and normal saline use for chronic exit site care in peritoneal dialysis patients. Kidney Res Clin Pract. 2014;33(3):144–9.
Li PK, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30(4):393–423.
Strippoli GF, et al. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis. 2004;44(4):591–603.
Vychytil A, et al. New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography. J Am Soc Nephrol. 1998;9(2):290–6.
Kwan TH, et al. Ultrasonography in the management of exit site infections in peritoneal dialysis patients. Nephrology (Carlton). 2004;9(6):348–52.
Lui SL, et al. Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection. Adv Perit Dial. 2000;16:195–7.
Crabtree JH, Burchette RJ. Surgical salvage of peritoneal dialysis catheters from chronic exit-site and tunnel infections. Am J Surg. 2005;190(1):4–8.
Wu YM, et al. Surgical management of refractory exit-site/tunnel infection of Tenckhoff catheter: technical innovations of partial replantation. Perit Dial Int. 1999;19(5):451–4.
Mahajan S, et al. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population. Perit Dial Int. 2005;25(5):473–7.
Lobbedez T, et al. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant. 2004;19(12):3140–3.
Mahaldar A, Weisz M, Kathuria P. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis. Adv Perit Dial. 2009;25:56–9.
Port FK, et al. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int. 1992;42(4):967–74.
Fahim M, et al. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis. 2010;55(4):690–7.
Wang AY, et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis. 2000;36(6):1183–92.
Miles R, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int. 2009;76(6):622–8.
Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int. 2010;30(6):619–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Ho, L.T. (2017). Infectious Complications of Peritoneal Dialysis. In: Haggerty, S. (eds) Surgical Aspects of Peritoneal Dialysis. Springer, Cham. https://doi.org/10.1007/978-3-319-52821-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-52821-2_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52820-5
Online ISBN: 978-3-319-52821-2
eBook Packages: MedicineMedicine (R0)